|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0007634,
umls-concept:C0013125,
umls-concept:C0034656,
umls-concept:C0036525,
umls-concept:C0078257,
umls-concept:C0205171,
umls-concept:C0282460,
umls-concept:C0442027,
umls-concept:C0450442,
umls-concept:C0684249,
umls-concept:C1522484,
umls-concept:C1708063
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-6-6
|
|
pubmed:abstractText |
Many patients with metastatic nonsmall cell lung carcinoma (NSCLC) cannot tolerate intravenous chemotherapy. Orally active agents would be more convenient and thus could improve their quality of life.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
245-51
|
|
pubmed:meshHeading |
pubmed-meshheading:17551300-Administration, Oral,
pubmed-meshheading:17551300-Adult,
pubmed-meshheading:17551300-Aged,
pubmed-meshheading:17551300-Aged, 80 and over,
pubmed-meshheading:17551300-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17551300-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17551300-Female,
pubmed-meshheading:17551300-Humans,
pubmed-meshheading:17551300-Infusions, Intravenous,
pubmed-meshheading:17551300-Lung Neoplasms,
pubmed-meshheading:17551300-Male,
pubmed-meshheading:17551300-Middle Aged,
pubmed-meshheading:17551300-Vinblastine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.
|
|
pubmed:affiliation |
Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. vera.hirsh@muhc.mcgill.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
